Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5127265

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of BTK C481S mutant (unknown origin)
5
Total Activities
5
Compounds Tested
2
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

Tyrosine-protein kinase BTK (CHEMBL5251)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.
Ran F, Liu Y, Wang C, Xu Z, Zhang Y, Liu Y, Zhao G, Ling Y.
Eur J Med Chem (2022) 229 : 114009 -114009
PubMed 34839996 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 4 8.60 9.41
Ki 1 8.80 8.80

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL4756476 NEMTABRUTINIB 3.0 1 9.41
CHEMBL4065122 FENEBRUTINIB 3.0 1 8.80
CHEMBL5169992 1 8.60
CHEMBL1230541 1 7.80
CHEMBL4650485 PIRTOBRUTINIB 4.0 1 -

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL4756476 NEMTABRUTINIB IC50 = 0.39 nM 9.41
CHEMBL4065122 FENEBRUTINIB Ki = 1.6 nM 8.80
CHEMBL5169992 IC50 = 2.5 nM 8.60
CHEMBL1230541 IC50 = 16.0 nM 7.80
CHEMBL4650485 PIRTOBRUTINIB IC50 < 1.0 nM -